21/04/2015 - 20:32 Metastatic triple-negative breast cancer appears to be the latest hard-to-treat cancer to yield to the juggernaut that is now anti-PD-L1 immunotherapy... More » Visit websiteField of Interest: OncologyCategories: CME-candidateONCR || NewsONCR || BreastOBGYN || NewsOBGYN || Breast CancerIMN || NewsIMN || OncologyNews Feed: Internal Medicine News - Oncology
